Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure

Published:2021-08-08 Issue:11 Volume:36 Page:3233-3238
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Shi Mingxia¹^ORCID,Sheng Li¹,Lian Min¹,Miao Qi¹,Wang Qixia¹,Xiao Xiao¹,Ma Xiong¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15629

Reference26 articles.

1. Characterization and treatment of persistent hepatocellular secretory failure

2. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

3. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy

4. Unexpected Clinical Remission of Cholestasis After Rifampicin Therapy in Patients With Normal or Slightly Increased Levels of Γ-Glutamyl Transpeptidase

5. Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2022-09-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP